Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the stock exchange about the schedule of an upcoming meeting. The filing is a routine disclosure under SEBI listing regulations, requiring companies to inform exchanges in advance of scheduled investor or analyst interactions. No specific agenda, topics, or financial details were disclosed in this filing. The actual meeting details (date, mode, and participants) would typically follow in the detailed schedule.
This is a routine compliance disclosure with no material impact on the stock. Investors should watch for any subsequent detailed announcement that may reveal the purpose and content of the meeting.